慢性充血性心力衰竭的研究进展  

Research progress of chronic congestive heart failure

作　　者：翟优 邓林华 赵英强[2] Zhai You;Deng Linhua;Zhao Yingqiang(Tianjin University of Traditional Chinese Medicine,Tianjin 301617,China;The Second Affiliated Hospital of Tianjin University of traditional Chinese Medicine,Tianjin 300250,China)

机构地区：[1]天津中医药大学,天津301617 [2]天津中医药大学第二附属医院,天津300250

出　　处：《医药前沿》2020年第21期12-13,共2页Journal of Frontiers of Medicine

摘　　要：慢性心力衰竭是心血管疾病的终末状态,严重危害人们的身心健康和生活质量,同时给社会及患者家庭带来了沉重的经济负担。经过长期的研究,慢性心力衰竭的发病机制逐渐被人们所认识,但仍不明确。本文对慢性心力衰竭的发病机制可能与舒张和(或)收缩功能障碍、心肌重塑及相关治疗药物的研究做一综述,为临床提供参考。Chronic heart failure(CHF)is the terminal state of cardiovascular disease,which seriously harms people's physical and mental health and quality of life,and at the same time brings heavy economic burden to the society and the families of patients.After a long period of research,the pathogenesis of chronic heart failure is gradually understood,but still unclear.It is suggested that the pathogenesis of chronic heart failure may be related to diastolic and/or systolic dysfunction and myocardial remodeling,and the research on related therapeutic drugs is reviewed to provide clinical reference.

关 键 词：依那普利 肼苯哒嗪 硝酸异山梨酯 慢性充血性心力衰竭 

分 类 号：R541.61[医药卫生—心血管疾病]